Newco news Reinvented Coimmune has a new IND and two clinical trials Feb. 19, 2020 By Lee Landenberger No Comments It’s been a rapid year of change for Coimmune Inc., which was incorporated only 12 months ago and now has FDA approval of an IND clearing the way for a phase IIb trial using CMN-001 to treat advanced metastatic renal cell carcinoma (mRCC).Read More